title: US trade rep is pressing Indian government to forbid production of generic cancer drug, consortium says.
authors.affiliation: The BMJ.
authors.forename: Deborah
authors.initials: D
authors.lastname: Cohen
mesh_terms: D000970:Antineoplastic Agents / Q000191:economics*; D003132:Commerce / Q000191:economics* / Q000941:ethics; D000069439:Dasatinib; D034462:Dissent and Disputes; D004345:Drug Industry / Q000191:economics* / Q000941:ethics; D016568:Drugs, Generic / Q000191:economics*; D006297:Health Services Accessibility / Q000191:economics* / Q000941:ethics; D006801:Humans; D007194:India; D011743:Pyrimidines / Q000191:economics*; D013844:Thiazoles / Q000191:economics*; D014481:United States
chemical_list: D000970:Antineoplastic Agents; D016568:Drugs, Generic; D011743:Pyrimidines; D013844:Thiazoles; D000069439:Dasatinib